Brief: Theranexus End-June Cash Position Of 11.6 Million Euros
Sept 27 (Reuters) - Theranexus SA ALTHX.PA :
* THERANEXUS ANNOUNCES ITS FINANCIAL RESULTS FOR THE FIRST
HALF OF
2022
* ON 30 JUNE 2022, THERANEXUS HAD A CASH POSITION OF EUR
11.6
MILLION
* H1 OPERATING INCOME EUR 0.5 MILLION VERSUS EUR 12,000 YEAR
AGO
* H1 NET LOSS EUR 3.3 MILLION VERSUS LOSS EUR 3.7 YEAR AGO
* H1 NET SALES EUR 0 MILLION VERSUS EUR 0 MILLION YEAR AGO
Source text for Eikon: ID:nACT76387
Further company coverage: ALTHX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease